Direktorat Registrasi ObatValid

MEROPENEM TRIHYDRATE

BPOM Number: GKL1515623944A1
Approved: 13 April 2026
Expiry: 31 March 2031
Form: SERBUK INJEKSI

About This Registration

MEROPENEM TRIHYDRATE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL1515623944A1. Its current registration status is Valid, with the licence valid until 31 March 2031. The product is registered to MEPROFARM and manufactured by MEPROFARM - INDONESIA. BPOM first approved this registration in March 2026. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 13 November 2025. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application: newaero
Packaging: DUS, 10 VIAL @ 0,5 G
Department: Direktorat Registrasi Obat
Data Last Updated: 13 November 2025

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

MEPROFARM
Kota Bandung, Jawa Barat, Indonesia
NPWP: 011310331441000
owner
View profile →

Manufacturing Sites

MEPROFARM - INDONESIA
KOTA BANDUNG
primary
View profile →

Ingredients (2)

MEROPENEM TRIHYDRATE BUFFERED WITH SODIUM CARBONATEMEROPENEM TRIHYDRATE BUFFERED SODIUM CARBONATE

Market Intelligence

Owner Portfolio: MEPROFARM holds 287 BPOM registrations
Manufacturer Scale: MEPROFARM - INDONESIA produces 281 registered products
Registration Age: Registered for 3 months

FDA Cross-Reference

via openFDA

Generic Name: MEROPENEM
Product Type: HUMAN PRESCRIPTION DRUG
Route of Administration: INTRAVENOUS

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?